Society for Immunotherapy of Cancer (SITC)
LuAnnabelle Wieseman is a skilled communications professional with a focus on marketing and digital engagement. Currently serving as Communications Manager for the Society for Immunotherapy of Cancer since June 2023, LuAnnabelle manages social media content, website updates, and advertising campaigns to enhance user engagement and participation in scientific programs. Prior experience includes roles as a Marketing Assistant at UW-Whitewater College of Business and Economics, where LuAnnabelle increased program awareness and managed multiple social media accounts, and as a Recruiting and Marketing Intern at The Panaro Group LLC, where LuAnnabelle executed marketing campaigns and sourced candidates. Additional experience encompasses various internships and roles focusing on digital marketing, SEO strategies, and customer service, complemented by a Bachelor of Business Administration in Marketing from the University of Wisconsin-Whitewater.
Society for Immunotherapy of Cancer (SITC)
The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. sitc_log_color.png Established in 1984, SITC, a 501(c)(3) not-for-profit organization, serves scientists, clinicians, academicians, patients, patient advocates, government representatives and industry leaders from around the world. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Currently, SITC has more than 2,000 members who represent 22 medical specialties in 42 countries around the world. Through emphasis on high-caliber scientific meetings; dedication to education and outreach activities; focus on initiatives of major importance in the field; and commitment to collaborations with like-minded domestic and international organizations, government and regulatory agencies, associations and patient advocacy groups, SITC brings together all aspects of the cancer immunology and immunotherapy community. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.